Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.cancertherapyadvisor.com/home/news/conference-coverage/san-antonio-breast-cancer-symposium-sabcs/sabcs-2023/t-dm1-falls-short-in-elderly-patients-with-advanced-her2-breast-cancer/
0
0
T-DM1 Falls Short in Elderly Patients With Advanced, HER2+ Breast Cancer - Cancer Therapy Advisor
12/8/23 at 2:40pm
Organization
Cancertherapyadvisor.com
Author
Bryant Furlow
Details
39 words
Summarize
Health
Cancer
T-DM1
T-DM1 Falls Short
pertuzumab
T-DM1 is not a viable alternative to standard trastuzumab, pertuzumab, and docetaxel for elderly patients with advanced HER2+ breast cancer, new data suggest.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...